Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Teresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, Luca Potestio & Matteo Megna. (2023) Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments. Clinical, Cosmetic and Investigational Dermatology 16, pages 1899-1932.
Read now
Read now
Rohan Singh, Alexandria M Brown, Warren H Chan, Morgan A Farr, Sid Venkataraman & Steven R Feldman. (2022) Psoriatic arthritis improved on risankizumab: does the presence of psoriatic arthritis mean a drug approved for psoriatic arthritis has to be prescribed?. Expert Opinion on Biological Therapy 22:12, pages 1439-1441.
Read now
Read now
Chen-Pu Yeh, Yi-Wei Huang & Tsen-Fang Tsai. (2022) Comparison of the relative efficacy of different biologics in different body areas in patients with moderate to severe psoriasis receiving biologics and tofacitinib in phase 3 randomized controlled trials: a 15-year single-center experience. Expert Review of Clinical Pharmacology 15:7, pages 887-895.
Read now
Read now
M Galluzzo, G Caldarola, C De Simone, N Bernardini, G Moretta, S Pallotta, E Botti, E Campione, F Pirro, C. Potenza, L Bianchi & K Peris. (2021) Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy. Expert Opinion on Biological Therapy 21:9, pages 1299-1310.
Read now
Read now
Paolo Gisondi & Giampiero Girolomoni. (2020) Brodalumab in the treatment of chronic plaque psoriasis. Expert Opinion on Biological Therapy 20:10, pages 1175-1186.
Read now
Read now
Hazrat Bilal, Muhammad Nadeem Khan, Sabir Khan, Wenjie Fang, Wenqiang Chang, Bin Yin, Ning-Jing Song, Zhongrong Liu, Dongxing Zhang, Fen Yao, Xun Wang, Qian Wang, Lin Cai, Bing Hou, Jiayue Wang, Chunyan Mao, Lingxi Liu & Yuebin Zeng. Risk of candidiasis associated with interleukin-17 inhibitors: implications and management. Mycology 0:0, pages 1-15.
Read now
Read now
Articles from other publishers (18)
Cathrine Dawn Büttner Elgaard, Lars Iversen & Kasper Fjellhaugen Hjuler. (2023) Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis. Drugs in R&D 23:2, pages 155-163.
Crossref
Crossref
Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, Paolo Dapavo, Gabriella Fabbrocini, Paolo Gisondi, Giuseppe Micali, Anna Maria Offidani, Giovanni Pellacani, Nevena Skroza, Rosa Giuseppa Angileri, Martina Burlando, Anna Campanati, Carlo Giovanni Carrera, Andrea Chiricozzi, Andrea Conti, Clara De Simone, Vito Di Lernia, Enzo Errichetti, Marco Galluzzo, Claudio Guarneri, Claudia Lasagni, Serena Lembo, Francesco Loconsole, Matteo Megna, Maria Letizia Musumeci, Francesca Prignano, Antonio Giovanni Richetta, Emanuele Trovato, Marina Venturini, Ketty Peris & Piergiacomo Calzavara Pinton. (2023) Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement. Journal of Clinical Medicine 12:10, pages 3545.
Crossref
Crossref
Manuel Galan‐Gutierrez, Pilar Font‐Ugalde, Laura Padilla, Carlos Hernandez‐Montoya, Daniel Godoy, Jose C. Armario‐Hita & Ricardo Ruiz‐Villaverde. (2022) Brodalumab: Efficacy, safety, and survival in mid‐term (52 weeks) on real clinical practice in Andalucia, Spain. International Journal of Dermatology 62:5, pages 700-706.
Crossref
Crossref
Estela García-Martín, RM Romero-Jiménez, Ofelia Baniandrés-Rodríguez, Vicente Escudero-Vilaplana, Juana Benedí-González, Paloma Morales de los Ríos Luna, Ana Herranz-Alonso & María Sanjurjo-Sáez. (2023) Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors. European Journal of Hospital Pharmacy, pages ejhpharm-2022-003594.
Crossref
Crossref
Natalia Rompoti, Maria Politou, Irene Stefanaki, Charitomeni Vavouli, Marina Papoutsaki, Afroditi Neofotistou, Dimitrios Rigopoulos, Alexander Stratigos & Electra Nicolaidou. (2023) Brodalumab in plaque psoriasis: Real‐world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks. Journal of the European Academy of Dermatology and Venereology 37:4, pages 689-697.
Crossref
Crossref
Dimitrios Rigopoulos, Charalampos Angelakopoulos, Zoi Apalla, Sophia Georgiou, Florentina Delli, Alexandros Drosos, Efterpi Zafiriou, John Katsantonis, Elisavet Lazaridou, Pantelis Panagakis, Evangelia Papadavid, Markos Papakonstantis, Angeliki‐Viktoria Roussaki‐Schulze, Elena Sotiriou, Georgios Anastasiadis, Eleftheria Tampouratzi, Vasiliki Chasapi, Konstantinos Sfaelos & Dimitrios Ioannides. (2022) Real world experience of brodalumab treatment in patients with moderate‐to‐severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study. Dermatologic Therapy 35:12.
Crossref
Crossref
Alan Menter, Tina Bhutani, Benjamin Ehst, Boni Elewski & Abby Jacobson. (2022) Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis. Dermatology and Therapy 12:6, pages 1289-1302.
Crossref
Crossref
Shinichi Imafuku, Chika Ohata, Yukari Okubo, Rie Tobita, Hidehisa Saeki, Tomotaka Mabuchi, Yuki Hashimoto, Kenta Murotani, Hiroki Kitabayashi & Yasumasa Kanai. (2022) Effectiveness of brodalumab in achieving treatment satisfaction for patients with plaque psoriasis: The ProLOGUE study. Journal of Dermatological Science 105:3, pages 176-184.
Crossref
Crossref
Rob Leland Shaver, Michelle A. Lowes & Noah Goldfarb. 2022. A Comprehensive Guide to Hidradenitis Suppurativa. A Comprehensive Guide to Hidradenitis Suppurativa
321
331
.
Christiana Doulami, Andrew J.T. George & Uday Kishore. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
755
762
.
Carmen RODRÍGUEZ-CERDEIRA, José L. GONZÁLEZ-CESPÓN, Erick MARTÍNEZ-HERRERA, Miguel CARNERO-GREGORIO, Adriana LÓPEZ-BARCENAS, Alexey SERGEEV & Ditte M. SAUNTE. (2021) Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management. Italian Journal of Dermatology and Venereology 156:5.
Crossref
Crossref
Dimitrios Rigopoulos, Natalia Rompoti & Stamatios Gregoriou. (2021) Management of Nail Psoriasis. Dermatologic Clinics 39:2, pages 211-220.
Crossref
Crossref
M.C. Fargnoli, M. Esposito, P. Dapavo, A. Parodi, M. Rossi, R. Tiberio, S. Dastoli, A.M. Offidani, G. Argenziano, P. Gisondi, A. Lo Schiavo, F. Loconsole, P. Pella, F. Bardazzi, F. Cusano, M. Gattoni, M. Nacca, S.P. Cannavò, C. Pellegrini, A. Costanzo, G. Pertusi, E. Stroppiana, A. Gambardella, F. Romano, C. Sassetti, A. Carpentieri, F. Bellinato, M. Burlando, F. Graziola, L. Sacchelli, A. Campanati & G. Ronza. (2020) Brodalumab for the treatment of moderate‐to‐severe plaque‐type psoriasis: a real‐life, retrospective 24‐week experience. Journal of the European Academy of Dermatology and Venereology 35:3, pages 693-700.
Crossref
Crossref
Elisa Camela, Sonia Sofía Ocampo‐Garza, Eleonora Cinelli, Alessia Villani, Gabriella Fabbrocini & Matteo Megna. (2021) Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review. Dermatologic Therapy 34:2.
Crossref
Crossref
Marcel C. Pasch & Matilde Iorizzo. 2021. Advances in Nail Disease and Management. Advances in Nail Disease and Management
129
170
.
Ricardo Ruiz‐Villaverde, Manuel Galán‐Gutierrez, Jose Carlos Armario‐Hita, Jose Carlos Ruiz‐Carrascosa & Pilar Font‐Ugalde. (2020) Brodalumab: short‐term effectiveness and safety in real clinical practice. International Journal of Dermatology 59:9.
Crossref
Crossref
Marina Luise Viola Azevedo, Mineia Alessandra Scaranello Malaquias, Caroline Busatta Vaz de Paula, Cleber Machado de Souza, Victor Horácio Costa Júnior, Sonia Mara Raboni, Renata Halila, Giuliana Rosendo, Priscilla Gozzo, Leticia Arianne Panini do Carmo, Plínio Cézar Neto, Seigo Nagashima & Lucia de Noronha. (2020) The role of IL-17A/IL-17RA and lung injuries in children with lethal non-pandemic acute viral pneumonia. Immunobiology 225:4, pages 151981.
Crossref
Crossref
Dimitrios Rigopoulos, Anna Stathopoulou & Stamatios Gregoriou. (2020) Small Molecules and Biologics in the Treatment of Nail Psoriasis. Skin Appendage Disorders 6:3, pages 134-141.
Crossref
Crossref